Why the study?
Does magnetocardiography (MCG) accurately localize arrhythmogenic substrates in patients with Wolff-Parkinson-White syndrome and ventricular tachycardia to guide catheter ablation?
Population
Patients with Wolff-Parkinson-White syndrome and patients with ventricular tachycardia
Design
Review
Authors
Loading...
May support noninvasive localization for WPW/VT ablation; leaves open prospective trials before clinical adoption.
Does magnetocardiography (MCG) accurately localize arrhythmogenic substrates in patients with Wolff-Parkinson-White syndrome and ventricular tachycardia to guide catheter ablation?
Magnetocardiography is emerging as an accurate noninvasive tool for localizing arrhythmogenic substrates to guide catheter ablation in WPW and VT.
Fenici et al. (1995) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: